These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 15343569)

  • 41. Predictors of outcome after sirolimus-eluting stent implantation for complex in-stent restenosis.
    Migliorini A; Shehu M; Carrabba N; Giurlani L; Valenti R; Buonamici P; Dovellini EV; Parodi G; Antoniucci D
    Am J Cardiol; 2005 Oct; 96(8):1110-2. PubMed ID: 16214447
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Paclitaxel-eluting stents in treatment of stenoses and chronic occlusions of coronary arteries].
    Maslov LN; Krylov AL
    Angiol Sosud Khir; 2007; 13(3):53-60. PubMed ID: 18382394
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Delayed strut fracture of sirolimus-eluting stent: a significant problem or an occasional observation?
    Min PK; Yoon YW; Moon Kwon H
    Int J Cardiol; 2006 Jan; 106(3):404-6. PubMed ID: 16337054
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents.
    Kastrati A; Dibra A; Mehilli J; Mayer S; Pinieck S; Pache J; Dirschinger J; Schömig A
    Circulation; 2006 May; 113(19):2293-300. PubMed ID: 16682614
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomized trial versus registry data--comparing apples and ORCHIDs.
    Moliterno DJ
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):669-70. PubMed ID: 17039505
    [No Abstract]   [Full Text] [Related]  

  • 46. Percutaneous coronary revascularization of diabetic patients in the era of drug-eluting stents.
    Kereiakes DJ; Young JJ
    Rev Cardiovasc Med; 2005; 6 Suppl 1():S48-58. PubMed ID: 15665798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Restenosis treatment in the drug-eluting stent era.
    Presbitero P; Boccuzzi G
    Ital Heart J; 2005 Jun; 6(6):514-21. PubMed ID: 16008157
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
    Lee JY; Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Park SW; Park SJ
    J Am Coll Cardiol; 2009 Aug; 54(9):853-9. PubMed ID: 19695467
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial.
    Fajadet J; Morice MC; Bode C; Barragan P; Serruys PW; Wijns W; Constantini CR; Guermonprez JL; Eltchaninoff H; Blanchard D; Bartorelli A; Laarman GJ; Perin M; Sousa JE; Schuler G; Molnar F; Guagliumi G; Colombo A; Ban Hayashi E; Wülfert E
    Circulation; 2005 Mar; 111(8):1040-4. PubMed ID: 15723977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Day in and day out.
    Holmes DR
    Catheter Cardiovasc Interv; 2004 May; 62(1):30. PubMed ID: 15103596
    [No Abstract]   [Full Text] [Related]  

  • 51. Preventing restenosis with stent drug coatings.
    Belardi J
    J Invasive Cardiol; 2002 Sep; 14(9):576-82. PubMed ID: 12369563
    [No Abstract]   [Full Text] [Related]  

  • 52. Bifurcation disease: optimal angiographic result yet suboptimal long-term outcome.
    Pershad A
    Catheter Cardiovasc Interv; 2004 Sep; 63(1):104. PubMed ID: 15343578
    [No Abstract]   [Full Text] [Related]  

  • 53. Stents wars.
    Kremastinos D
    Hellenic J Cardiol; 2007; 48(6):387. PubMed ID: 18196665
    [No Abstract]   [Full Text] [Related]  

  • 54. Is zero enough?
    Gonschior P
    J Invasive Cardiol; 2002 Sep; 14(9):514. PubMed ID: 12205349
    [No Abstract]   [Full Text] [Related]  

  • 55. Suboptimal percutaneous coronary intervention.
    Kaneda H
    Am J Cardiol; 2008 Oct; 102(7):954. PubMed ID: 18805130
    [No Abstract]   [Full Text] [Related]  

  • 56. Six-months patency of three long drug eluting stents documented by surveillance coronary multi-detector computed tomography (MDCT).
    Movahed MR
    Clin Res Cardiol; 2006 Nov; 95(11):605-9. PubMed ID: 16897140
    [No Abstract]   [Full Text] [Related]  

  • 57. Contribution of transplantation to the development of medical science. How transplantation contributes to the world of medicine.
    Paczek L; Foroncewicz B
    Ann Transplant; 2006; 11(2):29-31; discussion 32-43. PubMed ID: 17494287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Passive coating: the dream does not come true.
    Colombo A; Airoldi F
    J Invasive Cardiol; 2003 Oct; 15(10):566-7. PubMed ID: 14519888
    [No Abstract]   [Full Text] [Related]  

  • 59. Interventional cardiology: evolution and future.
    Schatz RA
    Am Heart Hosp J; 2006; 4(3):202-4. PubMed ID: 16894257
    [No Abstract]   [Full Text] [Related]  

  • 60. Single-digit target vessel revascularization in multivessel coronary interventions with sirolimus-eluting stents: goodbye to coronary bypass grafting.
    Colombo A
    Catheter Cardiovasc Interv; 2004 Sep; 63(1):61-2. PubMed ID: 15343569
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.